J&J offers $5.5bn settlement in lawsuits claiming talc link to cancer
•Johnson & Johnson has proposed a $5.5 billion settlement for approximately 69,000 lawsuits alleging its talc-based baby powder caused ovarian cancer.
•The settlement resolves most outstanding talc-related cases in the US, but does not include ongoing litigation in the UK.
•J&J discontinued its talc-based baby powder in the US in 2020 and globally in 2023, despite maintaining that talc does not cause cancer.
play Live Sign upShow navigation menuNavigation menuNewsShow more news sectionsAfricaAsiaUS & CanadaLatin AmericaEuropeAsia PacificMiddle EastExplainedSportOpinionVideoMoreShow more sectionsFeaturesEconomyHuman RightsClimate CrisisInvestigationsInteractivesIn PicturesScience & TechnologyPodcastsTravelSponsored Contentplay Live Click here to searchsearchSign upNews|CourtsJ&J offers $5.5bn settlement in lawsuits claiming talc link to cancerSettlement resolves thousands of US lawsuits, with a record UK case against the company under way. xwhatsapp-strokecopylinkgoogleAdd Al Jazeera on GoogleinfoA bottle of Johnson and Johnson Baby Powder [File: Mike Segar/Reuters]By ReutersPublished On 28 Jul 202628 Jul 2026Johnson & Johnson (J&J) has agreed to pay $5.5bn to settle tens of thousands of lawsuits in the United States that allege its discontinued talc-based baby powder caused ovarian cancer. The pharmaceutical giant announced the deal on Monday, saying it covers about 69,000 cases in US federal and state courts, accounting for 99.75 percent of outstanding talc-related cases in the country. Talc is a soft mineral and was once a staple ingredient in cosmetics and baby products, but its use has declined as concerns rose over its links to cancer. In 2024, the World Health Organization classified talc as “probably carcinogenic to humans”. J&J maintains that there is no evidence that talc causes cancer, but it stopped selling talc-based baby powder in the US in 2020 and worldwide in 2023. In 2016, a US jury ordered J&J to pay $72m to the family of a woman who died of ovarian cancer, the first such case related to the use of the mineral in the country. Though the case was overturned a year later, claims against the company have multiplied since, with juries across the US awarding the plaintiffs. Erik Haas, J&J’s litigation head, said the agreement lets J&J “put this matter behind it”. Lawyers representing the plaintiffs welcomed the settlement as a good resolution to a decade-long court battle. The deal does not cover the United Kingdom, where the largest product liability case in UK history – covering more than 7,000 potential claimants – is being adjudicated. Filed in October 2025, the UK case alleges that J&J knew that its talc could cause cancers, chiefly ovarian and mesothelioma, but continued to sell the product, a claim the company also denies. The case has since gone before the UK High Court. Advertisement AboutAboutShow moreAbout UsCode of EthicsTerms and ConditionsEU/EEA Regulatory NoticePrivacy PolicyCookie PolicyCookie PreferencesAccessibility StatementSitemapWork for usConnectConnectShow moreContact UsUser Accounts HelpAdvertise with usStay ConnectedNewslettersChannel FinderTV SchedulePodcastsSubmit a TipPaid Partner ContentOur ChannelsOur ChannelsShow moreAl Jazeera ArabicAl Jazeera EnglishAl Jazeera Investigative UnitAl Jazeera MubasherAl Jazeera DocumentaryAl Jazeera BalkansAJ+Our NetworkOur NetworkShow moreAl Jazeera Centre for StudiesAl Jazeera Media InstituteLearn ArabicAl Jazeera Centre for Public Liberties & Human RightsAl Jazeera ForumAl Jazeera Hotel PartnersFollow Al Jazeera English:المصدر: Al Jazeera English | Source: Al Jazeera English
→Johnson & Johnson has proposed a $5.5 billion settlement for approximately 69,000 lawsuits alleging its talc-based baby powder caused ovarian cancer.
→The settlement resolves most outstanding talc-related cases in the US, but does not include ongoing litigation in the UK.
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Al Jazeera English. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Al Jazeera English. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.





